NIH-funded research R01 grant

Identifying biomarkers that predict TB disease risk in children with HIV

Official title: Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID)

Funded at Stellenbosch University · NIH-11519036 · Data updated 2026-11-12

Researchers will study stored samples from young children, including those with HIV, to find biological markers that signal who might develop TB or respond to treatment.

More Tuberculosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionStellenbosch University
NIH-funded
Lab location1 site (Stellenbosch, SOUTH AFRICA)
Project startMay 5, 2023
Project endApril 30, 2028
Funding year2026
Award (this year)$24,441
NIH project number3R01AI175235-04S2
Project IDNIH-11519036 on NIH RePORTER

Who could benefit from this research

Could help

Children exposed to TB, especially those who are HIV-infected or have HIV exposure, and who are part of longitudinal TB studies.

Less likely to help

Children without TB exposure or HIV infection may not benefit from this biomarker-focused approach.

What this research studies

This project will analyze existing samples from children in TB studies using blood-based and molecular profiling techniques to find signatures linked to progression to TB disease and how well treatment works. It will combine data from transcriptomics, proteomics, metabolomics, and antibody profiles with information on HIV status, co-infections, and clinical factors. The goal is to identify biomarker patterns that can guide targeted TB preventive therapy and improve patient care. The work will be conducted in collaboration with clinical teams in the United States and globally, leveraging stored samples and longitudinal data. Outcomes could directly influence how clinicians monitor and protect children exposed to TB.

Why it matters

Potential benefit: If successful, this research could enable earlier identification of children at highest risk for TB and tailor preventive treatment and monitoring accordingly.

How similar studies have gone: Previous biomarker studies in TB have identified signatures associated with disease risk, but this project aims to integrate multiple omics to improve predictive power in children and HIV contexts.

Where this research is happening

  • Stellenbosch University
    Stellenbosch, South Africa
    Active

Researchers

  • Principal investigator: Seddon, James Alexander — Stellenbosch University
  • Study coordinator: Seddon, James Alexander

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.